Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRCVM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,086
Award facts
- Contract value 100% obligated
- $26,086.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,086.28 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen (2 mL) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed price, competitively awarded contract represents a routine pharmaceutical supply delivery under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The place of performance is listed in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive $999.999 billion Indefinite Delivery Vehicle with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. Dupixent is a biologic medication commonly used to treat eczema, asthma, and chronic rhinosinusitis, reflecting the company's role in supplying specialty medications for Defense Health Agency and other government healthcare systems. The contract carries no set-aside designation and was awarded through open competition, demonstrating AmerisourceBergen Drug Corp's capability to meet federal procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FRCVM?
SPE2DB25FRCVM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FRCVM worth?
The government has obligated $26,086 on SPE2DB25FRCVM.
Is contract SPE2DB25FRCVM an order under another contract?
Yes. SPE2DB25FRCVM is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRCVM competed?
The extent of competition for SPE2DB25FRCVM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award